Your Location：
Home >
Browse articles >
Sorafenib in hepatocellular carcinoma:efficacy and predictive factors
Updated：2026-03-12
Previous|Next

    • Sorafenib in hepatocellular carcinoma:efficacy and predictive factors

    • Li Jing , Huang Liang , Yan Jianjun , Zhou Feiguo , Liu Caifeng , Yan Yiqun~ Department of Hepatic Surgery I , Eastern Hepatobiliary Surgery Hospital , Second Military Medical University , Shanghai 200438 , China
    • Military Medical Research Vol. 26, Issue 6, Pages: 324-334(2011)

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

5

Views

16

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Frostbite: diagnosis, treatment, prognosis, and future directions
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Related Author

No data

Related Institution

No data